Mario Lemieux Center for Blood Cancers
Dr. Agha at the Mario Lemieux Center for Blood Cancer | UPMC Hillman
Mario Lemieux Center for Blood Cancers

Health Alert:

Your health can’t wait. Learn how we’re making our facilities safer and schedule your care now.

Our Treatment for Leukemia at the Mario Lemieux Center for Blood Cancers

Leukemia results from an overproduction of abnormal cells in the bone marrow. At the Mario Lemieux Center for Blood Cancers, we treat all types of leukemia, including:

  • Acute lymphoblastic leukemia
  • Acute lymphocytic leukemia
  • Acute myeloid leukemia
  • Chronic lymphocytic leukemia
  • Chronic myeloid leukemia
Contact the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center

Request an Appointment

To schedule an appointment, call 412-864-6600.

Schedule now.

Our Treatment Approach

The Mario Lemieux Center for Blood Cancers provides patients with access to a team of highly trained and experienced leukemia specialists. We were the first in western Pennsylvania to provide FDA-approved CAR T-cell therapy for young adult patients with acute lymphoblastic leukemia (ALL), and our experts use the latest and most effective diagnostic procedures and treatments for patients with all types and stages of the disease.

Our physicians work together and routinely discuss cases to develop the most appropriate treatment plans for your type and stage of disease based on the latest research and your:

  • Disease characteristics
  • Overall health
  • Social situation
  • Treatment goals
  • Current treatment guidelines
  • Eligibility for clinical trials

We have more than 30 years of experience in stem cell transplantation and are collaborating on—and sometimes leading—industry-sponsored clinical trials investigating the latest immunotherapies for leukemia. Our customized plans may include stem cell transplantation and immunotherapy, such as CAR T-cell therapy, based on your individual needs.

Leukemia Clinical Trials

The Mario Lemieux Center for Blood Cancers offers leukemia clinical trials to provide patients with access to new treatments that may not be available elsewhere.

We currently offer clinical trials for: